Extracellular ascorbate stabilization as a result of transplasma electron transfer in Saccharomyces cerevisiae.
The presence of yeast cells in the incubation medium prevents the oxidation of ascrobate catalyzed by copper ions. Ethanol increases ascorbate retention. Pyrazole, an alcohol dehydrogenase inhibitor, prevents ascorbate stabilization by cells. Chelation of copper ions does not account for stabilization, since oxidation rates with broken or boiled cells or conditioned media are similar to control rates in the absence of cells. Protoplast integrity is needed to reach optimal values of stabilization. Chloroquine, a known inhibitor of plasma membrane redox systems, inhibits the ascorbate stabilization, the inhibition being partially reversed by coenzyme Q6. Chloroquine does not inhibit ferricyanide reduction. Growth of yeast in iron-deficient media to increase ferric ion reductase activity also increases the stabilization. In conclusion, extracellular ascorbate stabilization by yeast cells can reflect a coenzyme Q dependent transplasmalemma electron transfer which uses NADH as electron donor. Iron deficiency increases the ascorbate stabilization but the transmembrane ferricyanide reduction system can act independently of ascorbate stabilization.
Santos-Ocaña
C
C
Departamento de Biología Celular, Universidad de Córdoba, Spain.
Navas
P
P
Crane
F L
FL
Córdoba
F
F
D001205:Ascorbic Acid / Q000378:metabolism*; D002462:Cell Membrane / Q000378:metabolism; D002738:Chloroquine / Q000494:pharmacology; D004579:Electron Transport; D004791:Enzyme Inhibitors / Q000494:pharmacology; D000431:Ethanol / Q000494:pharmacology; D005292:Ferricyanides / Q000378:metabolism; D007700:Kinetics; D009243:NAD / Q000378:metabolism; D009247:NADH, NADPH Oxidoreductases / Q000378:metabolism; D010084:Oxidation-Reduction; D011720:Pyrazoles / Q000494:pharmacology; D012441:Saccharomyces cerevisiae / Q000187:drug effects / Q000254:growth & development / Q000378:metabolism*; D013439:Sulfhydryl Reagents / Q000494:pharmacology; D014451:Ubiquinone / Q000031:analogs & derivatives / Q000494:pharmacology
D004791:Enzyme Inhibitors; D005292:Ferricyanides; D011720:Pyrazoles; D013439:Sulfhydryl Reagents; D009243:NAD; D014451:Ubiquinone; D000431:Ethanol; C031280:pyrazole; D002738:Chloroquine; D009247:NADH, NADPH Oxidoreductases; C014227:ferricyanide reductase; C003741:ubiquinol; D001205:Ascorbic Acid